Literature DB >> 24464621

Transformation of Brevibacillus, a soil microbe to an uropathogen with hemagglutination trait.

S C Suneeva1, R Prasanth, N G Rajesh, P Viswanathan.   

Abstract

An urinary tract infection (UTI) with Brevibacillus agri, an aerobic soil bacteria is discussed. The preliminary urine analysis tested negative for UTI, while the patient was diagnosed with focal pyelonephritis. The urine sample was analyzed for the presence of possible micro-organisms. The isolated micro-organism was phenotypically characterized and compared with a standard B. agri strain and an established uropathogen Eschericia coli, CFT073. Each experimental mouse was trans-urethrally infected using 2.5 × 10(8) c.f.u. for the generation of an UTI model. The kidney tissues were stored in buffered 10 % formaldehyde solution for histopathological analysis. The destruction of the glomerular and tubular morphology with prominent hemagglutination in the tubular region in the mouse kidneys were confirmed by light microscopic examination of the H&E stained sections. Hence, the identity of pathogen was confirmed using the 16S rRNA gene sequencing. The phylogenetic tree constructed using the 16S rRNA sequence obtained from the isolated microbial strain showed 99 % similarity with the strain, B. agri AB112716. Finally this study concludes based on the phenotypic characteristics, production of lipopolysaccharide, the ability to aggregate in the presence of ammonium sulphate, agglutinate erythrocytes in the presence of mannose, and the potential to resist the interactions of serum, the possibility that the soil microbe could have undergone genotypic modification to cause UTI. However, further detailed and in-depth genetic analysis are required to point out exactly how the soil bacterium has adapted itself to cause infection in a human subject.

Entities:  

Mesh:

Year:  2014        PMID: 24464621     DOI: 10.1007/s11274-014-1605-4

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  18 in total

Review 1.  Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 2.  Microbial communication and virulence: lessons from evolutionary theory.

Authors:  Stephen P Diggle
Journal:  Microbiology       Date:  2010-10-07       Impact factor: 2.777

3.  Occurrence and characterisation of uropathogenic Escherichia coli in urinary tract infections.

Authors:  R Raksha; H Srinivasa; R S Macaden
Journal:  Indian J Med Microbiol       Date:  2003 Apr-Jun       Impact factor: 0.985

Review 4.  Controversies in the laboratory diagnosis of community-acquired urinary tract infection.

Authors:  M G Morgan; H McKenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

5.  Use of ribotyping for characterization of Salmonella serotypes.

Authors:  E Esteban; K Snipes; D Hird; R Kasten; H Kinde
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  A murine model of urinary tract infection.

Authors:  Chia-Suei Hung; Karen W Dodson; Scott J Hultgren
Journal:  Nat Protoc       Date:  2009-07-30       Impact factor: 13.491

7.  Lipopolysaccharide subtypes of Haemophilus influenzae type b from an outbreak of invasive disease.

Authors:  T J Inzana; M E Pichichero
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

8.  GC-Profile: a web-based tool for visualizing and analyzing the variation of GC content in genomic sequences.

Authors:  Feng Gao; Chun-Ting Zhang
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

9.  Emerging pathogens: the epidemiology and evolution of species jumps.

Authors:  Mark E J Woolhouse; Daniel T Haydon; Rustom Antia
Journal:  Trends Ecol Evol       Date:  2005-05       Impact factor: 17.712

10.  Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP.

Authors:  Claudia M Müller; Anna Aberg; Jurate Straseviçiene; Levente Emody; Bernt Eric Uhlin; Carlos Balsalobre
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.